Natriumchloride Kabipac (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchloride Kabipac, is an electrolyte presented as an injection solution for intravenous use. It restores extracellular sodium and chloride concentrations and expands intravascular volume, helping to treat hypovolemia, electrolyte depletion and fluid loss in patients requiring rapid rehydration. GNH USA supplies Natriumchloride Kabipac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchloride Kabipac is used in the management of conditions involving fluid and electrolyte imbalance. - Hypovolemia: restores circulating blood volume and improves tissue perfusion. - Electrolyte depletion: replenishes sodium and chloride levels to maintain cellular function. - Fluid replacement: provides isotonic fluid for patients unable to maintain adequate hydration orally or enterally.

Natriumchloride Kabipac may be associated with adverse reactions following intravenous infusion.

Common Side Effects: - Phlebitis: inflammation at the infusion site. - Infiltration: leakage of solution into surrounding tissue. - Mild hypertension: transient increase in blood pressure.

Serious or Rare Side Effects: - Hypernatremia: elevated serum sodium causing neurological symptoms. - Hyperchloremic metabolic acidosis: disturbance in acid‑base balance. - Allergic reaction: rash, itching, or anaphylaxis in rare cases.

When using Natriumchloride Kabipac, clinicians should consider several safety measures. - Monitor electrolytes: check serum sodium and chloride regularly. - Assess fluid status: evaluate volume status before and during therapy. - Caution in heart failure: avoid fluid overload. - Adjust infusion rate in children: use pediatric guidelines. - Renal impairment: modify volume based on kidney function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Natriumchloride Kabipac can interact with other medications affecting fluid and electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline solutions: may cause severe hypernatremia. - Potassium chloride admixtures: risk of precipitation and vascular irritation. - Rapid blood product infusion: can exacerbate volume overload.

Moderate Interactions (Monitor Closely): - Diuretics: may increase electrolyte loss, requiring closer monitoring. - ACE inhibitors or ARBs: can potentiate changes in renal perfusion. - NSAIDs: may affect renal function and sodium handling.